Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice.

CONCLUSION: Our results demonstrated that overexpression of Sema3A in oral cancer cells drastically suppressed tumor growth by inhibiting angiogenesis. Our findings provide a basis for the development of novel therapeutics in the management of oral cancer.
PMID: 28683823 [PubMed - in process]

Source: BMC Pharmacology and Toxicology - July 8, 2017 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research